Inclusion Criteria:  OBC patients treated at TMH ER +/Her2 neg or TNBC We will include2780 women wherein events / 5-year follow up is available. We propose to have a blinded member of the DMG identify such cases and provide to the study team.  Exclusion Criteria:  . • Missing variables egpT size, chemotherapy details  Lost to follow up Her2 overexpression positive or Equivocal on IHC. (This is being excluded to avoid the bias of incomplete treatment as a large number of patients treated in 2010-2013 may not have received Her2 targeted treatment in our setting)